Detalhe da pesquisa
1.
VANDA regimen followed by blinatumomab leads to favourable outcome in patients with Philadelphia chromosome-negative B-precursor acute lymphoblastic leukaemia in first relapse.
Br J Haematol
; 198(3): 523-527, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35524489
2.
Dismal outcome of refractory or relapsing patients with myelodysplasia-related acute myeloid leukemia partially alleviated by intensive chemotherapy.
Cancer Med
; 13(3): e7003, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400682
3.
Azacitidine, intensive chemotherapy or best supportive care in relapsed or refractory acute myeloid leukemia, a DATAML registry study.
Leuk Lymphoma
; 63(6): 1398-1406, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35634787
4.
Clonal haematopoiesis and cardiovascular diseases: A growing relationship.
Arch Cardiovasc Dis
; 114(4): 316-324, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33714721
5.
Reduce Mortality and Morbidity in Acute Myeloid Leukemia With Hyperleukocytosis With Early Admission in Intensive Care Unit: A Retrospective Analysis.
J Hematol
; 9(4): 109-115, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33224390
6.
Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study.
Cancers (Basel)
; 12(8)2020 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32722211
7.
Outcome of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia Before Second-Generation FLT3 Tyrosine Kinase Inhibitors: A Toulouse-Bordeaux DATAML Registry Study.
Cancers (Basel)
; 12(4)2020 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32218221